| Stage | MAR | % of rev | TNL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.0B | 100.00% | $1.1B | 100.00% | MAR ×6.36 |
| Gross profit | $1.5B | 22.03% | $1.1B | 98.00% | TNL +76.0pp |
| Operating income | $1.3B | 18.19% | $195M | 17.71% | MAR +0.5pp |
| Pre-tax income | $1.1B | 15.13% | $146M | 13.26% | MAR +1.9pp |
| Net income | $794M | 11.33% | $108M | 9.81% | MAR +1.5pp |
| Stage | MAR | TNL | Gap · A − B |
|---|---|---|---|
| Revenue | $7.0B100.00% | $1.1B100.00% | MAR ×6.36 |
| Gross profit | 22.03%$1.5B | 98.00%$1.1B | TNL +76.0pp |
| Operating income | 18.19%$1.3B | 17.71%$195M | MAR +0.5pp |
| Pre-tax income | 15.13%$1.1B | 13.26%$146M | MAR +1.9pp |
| Net income |
| 11.33%$794M |
| 9.81%$108M |
| MAR +1.5pp |
No shared counterparties.